Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACT-541468 PK/PD and Safety in Healthy Adults and Elderly
NCT02571855Phase 1Completed
- Sponsor
- Idorsia
- Start
- Oct 2015
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of daridorexant in Insomnia (6 arms), sponsored by Idorsia. Primary endpoints: Number of participants with Adverse Events, Changes from baseline in ECG variables and vital signs and 1 more. Started Oct 2015; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02571855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02571855.